When a UV-curing grade changes, keep the first dosage comparison on an active-content basis. A nominal addition of 2.0% does not deliver the same initiator mass when one product is a neat solid and the other is a blend or solution. Normalize the active material first, then verify the lamp, film thickness, pigment load and cure endpoint in a controlled ladder study.
Separate nominal dosage from active dosage
Nominal dosage is the mass of commercial product added to the formulation. Active dosage is the mass of photoinitiator chemistry delivered by that addition. If a product is supplied at 80% active content, a 2.0% nominal addition delivers 1.6% active material on the same formulation basis.
Use this calculation when the supplier reports active content on the supplied product:
active dosage (%) = nominal product dosage (%) × active content (%) ÷ 100
To match an existing active dosage with a replacement product, use:
replacement nominal dosage (%) = target active dosage (%) ÷ replacement active content (%) × 100
Keep the basis consistent. A percentage on total formulation, binder solids, or resin-plus-monomer can produce different numbers even when the product mass is unchanged. Record the basis beside every trial result.
Worked example for a grade change
Assume a reference formula uses 2.0% of a neat photoinitiator. The target active dosage is therefore 2.0% on the selected formulation basis. A replacement grade documented at 80% active content would require 2.5% nominal product to deliver the same calculated active mass.
This is a bookkeeping conversion, not a guaranteed cure match. The replacement may absorb differently at the lamp wavelength, dissolve at a different rate, migrate differently, or change surface and through-cure balance. Treat the normalized value as the first point in the trial matrix.
Check the product form before weighing
Ask whether the quoted active content describes a neat solid, a solution, a blend, or a product containing a sensitizer or co-initiator. Also record the assay method, specification range, moisture or solvent statement, and document revision. If the active content is not disclosed, retain the supplier’s nominal dosage as a commercial-product value and avoid presenting an active-equivalent conversion as a measured fact.
For a 395 nm LED project, a product page such as CHLUMINIT OXE-06 should be checked together with its current specification and supplied form. For other grade-change work, compare the published information for CHLUMINIT PI-907 and CHLUMINIT PI-991 before choosing a trial level.
Use a small ladder study
Prepare a low, middle and high nominal level around the active-content-adjusted starting point. Keep resin, reactive diluent, pigment, coating thickness, lamp power, line speed and substrate constant. Measure the endpoint that matters to the application, such as tack-free surface, solvent rubs, through-cure, conversion, yellowing or residual odour.
- Keep the active-content calculation and the weighed commercial dosage in the trial record.
- Use the same lamp spectrum and dose when comparing grades.
- Separate surface cure from through-cure when interpreting the result.
- Repeat the best level after the blend has reached its intended age and temperature.
What the calculation cannot decide
Active-content normalization cannot establish compatibility, migration performance, storage stability or regulatory suitability. It also cannot replace a current technical document when the supplier changes the product form. Use the calculation to make the first comparison transparent, then approve the grade with application data tied to the exact batch and process.